| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.9 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.0064 | 0.9 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | -0.0086 | 0.9 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.9 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.0086 | 0.9 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | -0.0063 | 0.9 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | -0.007 | 0.9 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.0066 | 0.9 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | -0.0068 | 0.9 |